Suivez les dernières activités de délit d'initié Johnson & Johnson. Restez informé des achats, des ventes et de l'impact sur le marché des actions Johnson & Johnson.
L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.
À Johnson & Johnson, une activité interne récente a attiré l'attention. Au cours des 30 derniers jours, les initiés ont déclaré avoir vendu un total de - actions d'une valeur de -. ne signalez aucun achat au cours des 30 derniers jours.
Il n’y a eu aucun achat ou vente d’initié au cours des 90 derniers jours.
Oct 20, 2025 | EVP, INNOVATIVE MEDICINE, R&D | 0.00 | $175.31 | -$755.61K | SELL-OPTIONS | 0.00% | 10.66K | Oct 17 | ||
Sep 05, 2025 | EVP, WWC. INNOVATIVE MEDICINE | 0.00 | $139.84 | -$4.29M | SELL-OPTIONS | 0.00% | 178.01K | Sep 04 | ||
Aug 25, 2025 | CEO AND CHAIRMAN THE BOARD | 0.00 | $140.54 | -$9.73M | SELL-OPTIONS | 0.00% | 406.82K | Aug 22 | ||
Aug 18, 2025 | EXEC VP, CFO | 0.00 | $139.39 | -$1.26M | SELL-OPTIONS | 0.00% | 16.14K | Aug 15 | ||
Jul 18, 2025 | EVP, INNOVATIVE MEDICINE, R&D | -19.14K | $163.55 | -$3.13M | SELL | -64.23% | 10.66K | Jul 17 | ||
Feb 26, 2025 | VP CORPORATE CONTROLLER | 0.00 | $133.88 | -$448.01K | SELL-OPTIONS | 0.00% | 21.14K | Feb 25 | ||
Feb 18, 2025 | EVP, WW CHAIR, MEDTECH | 2.06K | $156.30 | -$193.03K | SELL-OPTIONS | 15.78% | 15.10K | Feb 13 - Feb 18 | ||
Feb 11, 2025 | EXEC VP, CFO | 0.00 | $126.97 | -$700.60K | SELL-OPTIONS | 0.00% | 2.11K | Feb 07 | ||
Dec 12, 2024 | DIRECTOR | 1.00K | $147.22 | $147.22K | BUY | ∞ | 1.00K | Dec 12 | ||
Sep 03, 2024 | VP CORPORATE CONTROLLER | 0.00 | $132.56 | -$366.27K | SELL-OPTIONS | 0.00% | 19.11K | Aug 30 | ||
Mar 13, 2024 | EVP, GLOBAL CORP AFFAIRS | -8.89K | $162.16 | -$1.44M | SELL | -37.15% | 15.04K | Mar 13 | ||
Feb 12, 2024 | EVP, WW CHAIR, PHARMACEUTICALS | 1.83K | $123.36 | -$4.21M | SELL-OPTIONS | 1.31% | 141.42K | Feb 08 - Feb 09 | ||
Jul 27, 2023 | EXEC VP, CHIEF HR OFFICER | -20.00K | $170.32 | -$3.41M | SELL | -16.30% | 102.70K | Jul 25 | ||
Jul 27, 2023 | SEE REMARKS | 0.00 | $131.22 | -$1.20M | SELL-OPTIONS | 0.00% | 87.75K | Jul 26 | ||
Jun 14, 2023 | EVP, CHIEF TO AND RISK OFFICER | -12.46K | $160.00 | -$1.99M | SELL | -15.84% | 66.21K | Jun 12 | ||
Mar 08, 2023 | SEE REMARKS | -1.06K | $154.66 | -$164.20K | SELL | -10.33% | 9.22K | Mar 06 | ||
Dec 15, 2022 | EXEC VP, CFO | -46.00 | $133.90 | -$1.35M | SELL | -0.12% | 37.80K | Apr 20 - Dec 13 | ||
Dec 02, 2022 | EVP, WW CHAIR, MEDTECH | 0.00 | $124.00 | -$7.55M | SELL-OPTIONS | 0.00% | 42.11K | Nov 30 | ||
Nov 23, 2022 | EVP, WW CHAIR, PHARMACEUTICALS | 0.00 | $124.66 | -$8.02M | SELL-OPTIONS | 0.00% | 126.46K | Nov 22 | ||
Nov 21, 2022 | CONTROLLER, CAO | 0.00 | $132.72 | -$1.43M | SELL-OPTIONS | 0.00% | 15.61K | Nov 18 | ||
Nov 10, 2022 | EVP, CHIEF GSC OFFICER | 0.00 | $122.98 | -$1.66M | SELL-OPTIONS | 0.00% | 71.59K | Nov 09 | ||
Nov 08, 2022 | EXEC VP, WW CHAIR, CONSUMER | 0.00 | $150.97 | -$1.42M | SELL-OPTIONS | 0.00% | 40.13K | Nov 04 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | -29.27K | $171.36 | -$5.02M | SELL | -20.34% | 114.68K | Oct 24 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | -20.85K | $171.19 | -$3.57M | SELL | -12.65% | 143.95K | Oct 24 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | -13.00K | $171.22 | -$2.23M | SELL | -7.31% | 164.80K | Oct 24 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | -8.26K | $171.14 | -$1.41M | SELL | -4.39% | 179.90K | Oct 24 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | -4.26K | $171.13 | -$729.52K | SELL | -2.25% | 184.86K | Oct 24 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | 75.64K | $143.35 | $8.59M | SELL-OPTIONS | 66.25% | 189.82K | Oct 24 | ||
Oct 26, 2022 | SEE REMARKS | 0.00 | $130.99 | -$1.22M | SELL-OPTIONS | 0.00% | 80.24K | Oct 24 | ||
Oct 21, 2022 | EXEC VP, CHIEF HR OFFICER | -22.86K | $164.50 | -$3.76M | SELL | -16.62% | 114.68K | Oct 19 | ||
Oct 21, 2022 | EXEC VP, CHIEF HR OFFICER | -29.95K | $164.50 | -$4.93M | SELL | -18.02% | 136.24K | Oct 19 | ||
Oct 21, 2022 | EXEC VP, CHIEF HR OFFICER | -13.70K | $164.50 | -$2.25M | SELL | -7.56% | 167.49K | Oct 19 | ||
Oct 21, 2022 | EXEC VP, CHIEF HR OFFICER | 66.51K | $133.19 | $6.55M | SELL-OPTIONS | 58.00% | 181.19K | Oct 19 | ||
Jun 14, 2022 | EVP, CHIEF GSC OFFICER | 0.00 | $122.77 | -$4.02M | SELL-OPTIONS | 0.00% | 71.59K | Jun 10 | ||
May 31, 2022 | CONTROLLER, CAO | 0.00 | $126.27 | -$909.33K | SELL-OPTIONS | 0.00% | 15.61K | May 26 | ||
Apr 25, 2022 | SEE REMARKS | 0.00 | $137.01 | -$2.77M | SELL-OPTIONS | 0.00% | 80.24K | Apr 21 | ||
Mar 21, 2022 | EXEC VP, WW CHAIR, CONSUMER | -23.68K | $176.25 | -$4.17M | SELL | -37.11% | 40.13K | Mar 17 | ||
Mar 21, 2022 | EXEC VP, WW CHAIR, CONSUMER | 19.91K | $138.48 | $1.18M | SELL-OPTIONS | 45.35% | 63.81K | Mar 17 | ||
Mar 17, 2022 | CONTROLLER, CAO | 0.00 | $124.02 | -$514.83K | SELL-OPTIONS | 0.00% | 15.61K | Mar 15 | ||
Dec 09, 2021 | CONTROLLER, CAO | 0.00 | $117.88 | -$453.35K | SELL-OPTIONS | 0.00% | 14.35K | Dec 07 | ||
Dec 10, 2020 | — | 0.00 | $107.57 | -$4.96M | OPTION EXERCISE | 0.00% | 57.35K | Dec 09 |
Parcourir transactions d'initiés sur toutes les actions.